Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328 (3 April), doi:10.1136/bmj.328.7443.0-d
Treating children with non-severe pneumonia with oral amoxicillin for three days, rather than five, is as effective, cheaper, and more likely to be adhered to by patients. In a randomised trial conducted by the ISCAP Study Group (p 791), 2188 children with non-severe pneumonia received oral amoxicillin for three days or standard care (five days' treatment). Clinical cures and relapses were no different in the two groups. Clinical failure was more likely with non-adherence to treatment at day 5, a respiratory rate of > 10 breaths/minute, and infection with respiratory syncytial virus. As well as being cheaper and as effective, a three day course may decrease antimicrobial resistance, the authors say.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?